Sleep quality and risk of obstructive sleep apnea among breast cancer survivors with and without lymphedema
Sleep and Breathing · 2025-03 · 29 (1)
DOI: 10.1007/s11325-024-03223-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep and Breathing, online erschienen am 03.12.2024. Verfasst von Masood Soltanipur und 4 weiteren Autor:innen. Beteiligte Einrichtung: Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Cancer Survivors, Breast Neoplasms, Sleep Quality. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Themen: Schlaf
Abstract (Originalsprache)
PURPOSE: Breast cancer survivors (BCSs) tend to have sleep disturbances such as obstructive sleep apnea (OSA). However, limited evidence exists on the role of breast cancer-related lymphedema (BCRL) in sleep disturbances and OSA. Therefore, this study aimed to investigate the quality of sleep (QoS) and OSA risk among women with and without BCRL. METHODS: The quality of life (QoL) was evaluated using the SF-12 and EORTC-QLQ C-30 questionnaires, while their sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) questionnaire. The STOP-bang questionnaire (SBQ) was utilized to quantify OSA risk. Sleepiness was assessed using the Epworth Sleepiness Scale (ESS). Also, neck and waist circumference and the excessive volume in the affected limb were measured using a tape measure. The statistical analyses were performed using the SPSS 21.0 software. RESULTS: Seventy-one women with BCRL and 84 BCS without lymphedema were included. The comparison of PSQI, SBQ, ESS, SF-12, and EORTC QLQ-C30 questionnaires exhibited no significant difference between these two groups. The overnight snoring and average neck circumference were significantly higher in the BCRL group than in the control. The BCRL stage significantly correlated with neck circumference and SBQ total score. Additionally, the mean volume difference indicated a significant correlation with the ESS total score and both physical and mental summary components of the SF-12 questionnaire. CONCLUSION: The prevalence of sleep disturbances among BCSs with and without BCRL is high. Women with advanced stages of BCRL might be at high risk for OSA. Therefore clinical evaluation of BMI, neck circumference, and, snoring overnight should be emphasized among this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
- ATMP Department, Breast Cancer Research Center, Motamed Cancer Research Institute, ACECR, Tehran, Iran.
- Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
- Population Health Research Group, Health Metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran.
- Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran. 954230010@shahed.ac.ir.
- Integrative Oncology Research Group, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran. 954230010@shahed.ac.ir.
Zitieren
APA
Soltanipur, M., Yarmohammadi, H., Abbasvandi, F., Montazeri, A., & Sheikhi, Z. (2025). Sleep quality and risk of obstructive sleep apnea among breast cancer survivors with and without lymphedema. Sleep and Breathing, 29(1). https://doi.org/10.1007/s11325-024-03223-w
Vancouver
Soltanipur M, Yarmohammadi H, Abbasvandi F, Montazeri A, Sheikhi Z. Sleep quality and risk of obstructive sleep apnea among breast cancer survivors with and without lymphedema. Sleep and Breathing. 2025;29(1). doi:10.1007/s11325-024-03223-w
BibTeX
@article{Soltanipur2025,
author = {Soltanipur, Masood and Yarmohammadi, Hossein and Abbasvandi, Fereshteh and Montazeri, Ali and Sheikhi, Zahra},
title = {Sleep quality and risk of obstructive sleep apnea among breast cancer survivors with and without lymphedema},
journal = {Sleep and Breathing},
year = {2025},
volume = {29},
number = {1},
doi = {10.1007/s11325-024-03223-w}
}
EUVIMED